MYGN icon

Myriad Genetics
MYGN

Overview Fund Activity

252 hedge funds and large institutions have $2.5B invested in Myriad Genetics in 2016 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 91 increasing their positions, 83 reducing their positions, and 25 closing their positions.

Holders
252
Holders Change
+19
Holders Change %
+8.15%
% of All Funds
6.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
46
Increased
91
Reduced
83
Closed
25
Calls
$8.7M
Puts
$26.4M
Net Calls
-$17.7M
Net Calls Change
-$8.69M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$30.3M
2
Morgan Stanley
2
Morgan Stanley
New York
$39M
3
RHJA
3
Rice Hall James & Associates
California
$16.1M
4
Millennium Management
4
Millennium Management
New York
$24.5M
5
RRAM
5
River Road Asset Management
Kentucky
$12.3M

Top Sellers

1
RIM
1
RS Investment Management
California
$0
2
IAM
2
Iridian Asset Management
Connecticut
$98.4M
3
Capital Research Global Investors
3
Capital Research Global Investors
California
$229M
4
SCM
4
Scopia Capital Management
New York
$142M
5
CIM
5
Contrarius Investment Management
Jersey
$2.77M
Name Holding Trade Value Shares
Change 		Shares
Change %
BWA
276
Burt Wealth Advisors
Maryland
– -$1K -8 Closed
8 9 10 11
12